Surgical management of small gastrointestinal stromal tumors of the stomach

被引:98
作者
Iwahashi, M
Takifuji, K
Ojima, T
Nakamura, M
Nakamori, M
Nakatani, Y
Ueda, K
Ishida, K
Naka, T
Ono, K
Yamaue, H
机构
[1] Wakayama Med Univ, Sch Med, Dept Surg 2, Wakayama 6418510, Japan
[2] Wakayama Med Univ, Sch Med, Dept Lab Med, Div Surg Pathol, Wakayama 6418510, Japan
关键词
D O I
10.1007/s00268-005-7944-4
中图分类号
R61 [外科手术学];
学科分类号
摘要
Small gastrointestinal stromal tumors (GISTs) (< 3 cm) occasionally are found in the stomach during endoscopy. There is no consensus about the surgical management of these small tumors, although this clinical issue is crucial because some of the tumors show unexpected malignant behavior. In this study, we evaluated the clinical management of patients with gastric GISTs who underwent surgical resection. Altogether, 31 patients with gastric GISTs were examined retrospectively. Surgical resection was fundamentally indicated for the patients with gastric GISTs suspected to be malignant by endoscopy or endoscopic ultrasonography (EUS). The malignant grade of the GISTs was evaluated by the mitotic rate, tumor size, and MIB-1 index. EUS was useful for differentiating benign from malignant GISTs; but by limiting the study to patients with small tumors (< 3 cm), the diagnostic value of EUS was not satisfactory for defining the surgical indication. Tumors that were < 50 mm were successfully treated by laparoscopic surgery. Of the 31 patients, 4 had a relapse of the disease, and 1 of those 4 patients had a small tumor (30 mm). All of the recurrences were classified in the high risk category. Surgery is indicated for gastric GISTs that are >= 20 mm or are suspected to be malignant based on EUS findings. Laparoscopic resection is feasible and is recommended as the treatment of choice for patients with tumors < 50 mm. Risk assessment can be most useful for predicting recurrence.
引用
收藏
页码:28 / 35
页数:8
相关论文
共 33 条
[1]   PROGNOSTIC VALUE OF PROLIFERATING CELL NUCLEAR ANTIGEN INDEX IN GASTRIC STROMAL TUMORS - CORRELATION WITH MITOTIC COUNT AND CLINICAL OUTCOME [J].
AMIN, MB ;
MA, CK ;
LINDEN, MD ;
KUBUS, JJ ;
ZARBO, RJ .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1993, 100 (04) :428-432
[2]   Laparoscopic treatment of gastric stromal tumors [J].
Basso, N ;
Rosato, P ;
De Leo, A ;
Picconi, T ;
Trentino, P ;
Fantini, A ;
Silecchia, G .
SURGICAL ENDOSCOPY-ULTRASOUND AND INTERVENTIONAL TECHNIQUES, 2000, 14 (06) :524-526
[3]   Gastrointestinal stromal tumors. [J].
Blanke C.D. ;
Eisenberg B.L. ;
Heinrich M.C. .
Current Treatment Options in Oncology, 2001, 2 (6) :485-491
[4]   Endosonographic differentiation of benign and malignant stromal cell tumors [J].
Chak, A ;
Canto, MI ;
Rosch, T ;
Dittler, HJ ;
Hawes, RH ;
Tio, TL ;
Lightdale, CJ ;
Boyce, HW ;
Scheiman, J ;
Carpenter, SL ;
VanDam, J ;
Kochman, ML ;
Sivak, MV .
GASTROINTESTINAL ENDOSCOPY, 1997, 45 (06) :468-473
[5]   Two hundred gastrointestinal stromal tumors - Recurrence patterns and prognostic factors for survival [J].
DeMatteo, RP ;
Lewis, JJ ;
Leung, D ;
Mudan, SS ;
Woodruff, JM ;
Brennan, MF .
ANNALS OF SURGERY, 2000, 231 (01) :51-58
[6]   Diagnosis of gastrointestinal stromal tumors: A consensus approach [J].
Fletcher, CDM ;
Berman, JJ ;
Corless, C ;
Gorstein, F ;
Lasota, J ;
Longley, BJ ;
Miettinen, M ;
O'Leary, TJ ;
Remotti, H ;
Rubin, BP ;
Shmookler, B ;
Sobin, LH ;
Weiss, SW .
HUMAN PATHOLOGY, 2002, 33 (05) :459-465
[7]   Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: Analysis of results in 140 surgically resected patients [J].
Yoshiya Fujimoto ;
Yukihiro Nakanishi ;
Kimio Yoshimura ;
Tadakazu Shimoda .
Gastric Cancer, 2003, 6 (1) :39-48
[8]   Cytologic diagnosis of gastrointestinal stromal tumors of the stomach by endoscopic ultrasound-guided fine-needle aspiration biopsy - Cytomorphologic and immunohistochemical study of 12 cases [J].
Gu, M ;
Ghafari, S ;
Nguyen, PT ;
Lin, F .
DIAGNOSTIC CYTOPATHOLOGY, 2001, 25 (06) :343-350
[9]   Gastrointestinal stromal tumor: Consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade [J].
Hasegawa, T ;
Matsuno, Y ;
Shimoda, T ;
Hirohashi, S .
HUMAN PATHOLOGY, 2002, 33 (06) :669-676
[10]   Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors [J].
Hirota, S ;
Isozaki, K ;
Moriyama, Y ;
Hashimoto, K ;
Nishida, T ;
Ishiguro, S ;
Kawano, K ;
Hanada, M ;
Kurata, A ;
Takeda, M ;
Tunio, GM ;
Matsuzawa, Y ;
Kanakura, Y ;
Shinomura, Y ;
Kitamura, Y .
SCIENCE, 1998, 279 (5350) :577-580